Alle disse additive faktorer ved anæmi skal også overvejes omhyggeligt, når der træffes beslutning om at øge cancerpatienters erytropoietindosis.
All of these additive factors of anaemia should also be carefully considered when deciding to increase the dose of erythropoietin in cancer patients.